CO26 Efficacy and Safety of First-Line Treatments for Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Systematic Review and Indirect Treatment Comparison
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.124
https://www.valueinhealthjournal.com/article/S1098-3015(22)00325-4/fulltext
Title :
CO26 Efficacy and Safety of First-Line Treatments for Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Systematic Review and Indirect Treatment Comparison
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00325-4&doi=10.1016/j.jval.2022.04.124
First page :
Section Title :
Open access? :
No
Section Order :
10104